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In the present study, the apoptotic eﬀect of cordycepin on MA-10 cells, a mouse Leydig tumor cell line, was investigated. Results
demonstrated that the number of rounding-up cell increased by cordycepin (10μMt o5m Mf o r2 4h ) ,a n dc e l l sw i t hp l a s m a
membrane blebbing could be observed by 100μM cordycepin. In viability test, MA-10 cell surviving rate signiﬁcantly decreased
as the dosage (10μM to 5mM) and duration (3–24h) of cordycepin treatment increased (P<. 05). Cordycepin at 100μM
and 1mM for 24h treatment induced signiﬁcant DNA fragmentation (P<. 05). In addition, the percentage of G1 and G2/M
phase cell signiﬁcantly declined by cordycepin (100μM and 1mM) for 24h treatment, while the percentages of subG1 phase
cell increased by 100μM and/or 1mM cordycepin in 6, 12, and 24h treatments (P<. 05), respectively, which highly suggested
that cordycepin induced MA-10 cell apoptosis. In mechanism study with the treatments of caspases, c-Jun NH2 terminal kinase
(JNK) or reactive oxygen species (ROS) inhibitors plus cordycepin for 24h, only caspases inhibitor suppressed subG1 phase in
MA-10 cells. Moreover, western blotting results showed that cordycepin induced caspase-9, -3 and -7 protein expressions, but not
caspase-8, in time- and dose-dependent manners. In conclusion, cordycepin induced apoptosis in MA-10 mouse Leydig tumor
cells through a caspase-9 and -3 and -7 dependent pathway.
1.Introduction
Cordycepin(3 deoxyadenosine),theanalogofadenosine,isa
constituent from the mycelia of Cordyceps sinensis (CS), and
was considered as an active component with eﬀects altering
cytokines secretion, improving lung function, increasing
energy levels and sex drive [1–3]. It has been demonstrated
that cordycepin has anti-tumor eﬀect on mouse melanoma
and lung carcinoma cells and human oral cancer cells
[4, 5]. Moreover, cordycepin could inhibit polyadenylate
polymerase (PAP) or inactivate mRNA polyadenylation to
induce tumor cell apoptosis, which is characterized by
the cellular rounding-up, cytoplasmic contraction, plasma
membrane blebbing, chromatin condensation, DNA frag-
mentation and many biochemical characteristics [6–11].
However, the molecular mechanisms regarding apoptotic
signal pathways remain elusive.
The activation of cystein aspartic-speciﬁc proteases
(caspases) is commonly thought to be one of the earliest
points in the no-return pathway of apoptosis. Caspases are
broadly categorized into upstream regulatory caspases and
downstream eﬀector caspases [12]. The upstream caspases,
such as caspase-8 (death receptor pathway) and caspase-9
(mitochondria pathway), typically have a long N-terminal
prodomain that facilitates interaction with and recruitment
of proapoptotic proteins, including other caspases [13]. The
downstream caspases, such as caspase-3, -6, and -7, typically
have short prodomains that primarily cleave protein, which
is important for cellular functions, and results in cell
apoptosis [9, 14–16]. Moreover, some investigations have
indicated that c-Jun NH2 terminal kinase (JNK) pathway
also participates in apoptosis. JNK, a stress-activated protein
kinase, is a subgroup of the MAPK superfamily, which can
b ea c t i v a t e db yc e l ls t r e s ss u c ha su l t r a v i o l e t ,T N Fa n d
interleukin-1 [17, 18]. Furthermore, reactive oxygen species
(ROS), molecules possessing an odd of electrons, could
induce various biological responses, including cell growth,
arrest and/or cell damage [19, 20]. Excess ROS would cause
damage to cellular component such as lipid membranes,
protein, and DNA, leading to apoptosis [21–23].
We have previously demonstrated that CS could induce
MA-10 cell apoptosis [24]. It is possible that cordycepin,2 Evidence-Based Complementary and Alternative Medicine
the pure substance from C. sinensis, induce MA-10 cell
death.Althoughsomereportshavedemonstratedthatcordy-
cepin possesses anti-tumor action, limited reports about
cordycepin-mediated apoptosis in testicular tumor cells have
been illustrated. In addition, it has been demonstrated that
between 1973 and 1995 the incidence of testicular cancer in
the United States increases 51% (1% of total cancer cases
annually),andorchidectomyisthecommonprotocoltotreat
testicular and Leydig cell cancers [25, 26]. Thus, rather than
orchidectomy, the exploration of cordycepin-induced cell
death with the study of mechanism will be valuable to design
moreeﬀectivechemotherapyagentsontesticulartumorcells.
2.MaterialsandMethods
2.1. Chemicals. Cordycepin, bovin serum albumin (BSA),
Waymouth MB 752/1 medium, 3-ethyl-5-benzyl-2-methyl-
4-phenylethylethynyl-6-phenyl-1,4-dihydropyridine-3,5-di-
carboxylate (MRS 1191), methylthiazolecterazolium (MTT),
SP600125, RNase A, propidium iodide and mercaptoethanol
were purchased from Sigma Chemical (St Louis, MO, USA).
Fetal bovine serum (FBS), Dulbecco’s phosphate buﬀered
saline,lyophilizedtrypsin-EDTAandgentamicinsulfatewere
purchased from Gibco (Grand Island, NY, USA). Sodium
hydroxide, hydrochloric acid, sodium dodecyl sulfate (SDS),
sucrose, EDTA, isopropyl alcohol, chloroform and Tween
20 were purchased from Merck (Darmstadt, Germany).
Tris base and general caspase inhibitor (zVAD-fmk) were
purchased from Calbiochem (San Diego, CA, USA).
Acrylamide was purchased from JT Baker (Phillipsburg,
NJ, USA). HEPES was purchased from Mallinckrodt
Baker, Inc. (Paris, Kentucky, USA). Tissue culture grade
sodium bicarbonate, sodium carbonate, sodium chloride,
sodium dihydrogen phosphate and potassium chloride were
purchased from Riedel-deHaen (Seelze, Germany). Donkey
anti-rabbit IgG conjugated with horseradish peroxidase
were purchased from Amersham International (Arlington
Heights, IL, USA). Antibody against β-actin and the
monoclonal antibody against caspase-3, -7, and -9 were
purchased from Cell Signaling (Beverly, MA, USA). The
polyclonal antibody against caspase-8 was purchased from
Santa Cruz (Santa Crus, CA, USA).
2.2. Cell Culture. The MA-10 cell line was a gift from Dr
Mario Ascoli (University of Iowa, Iowa City, IA, USA), and
was maintained with the standard technique [27]. Cells were
maintained in Waymouth medium containing 15% FBS and
incubated in a humidiﬁed atmosphere containing 95% air
and 5% CO2 at 37◦C.
2.3. Morphology Observation. MA-10 cells (6 × 105)w e r e
seeded in 6-cm Petri dish (Techno Plastic Products AG,
Trasadingen, Switzerland) with 2mL serum medium. After
70−80%conﬂuence,cellsweretreatedwithoutorwith10μM,
100μM, 1mM, 2mM and 5mM cordycepin for 24h. Cell
morphology was then observed and recorded under light
microscopy (Olympus, CK 40). Apoptosis is characterized
by the loss of cellular contact with the matrix and the
appearance of plasma membrane blebbing [9].
2.4. DNA Fragmentation Assay. In order to investigate if
cordycepin could induce cell apoptosis, DNA fragmentation
was determined ﬁrst. After treatment, MA-10 cells (1 ×
106) were lysed in a 0.6mL cell lysis solution containing
20mM Tris−HCl, 10mM EDTA, pH 8.0 and 0.3% Triton
X-100. DNA was extracted with 0.6mL phenol/chloroform
(1:1), and the mixture was centrifuged at 12500r.p.m. for
10 min. DNA in the aqueous phase was extracted with
phenol/chloroform (1:1) again. The aqueous phase with
DNA was mixed with isopropanol at −20◦C overnight.
After centrifugation, DNA pellets were washed with 70%
ethanol and air-dried. DNA pellets were dissolved in TE
buﬀer (10mM Tris−HCl, 1mM EDTA, pH 8.0), and RNase
A (3mg/mL) was added to remove RNA at 37◦C for 30 min.
DNA electrophoresis was carried out in 2% agarose gel. The
gelwasstainedwithethidiumbromide.DNAfragmentswere
visualized under UV light and photographed.
2.5. MTT Cytotoxicity Test. Methylthiazoletetrazolium test
was used to determine cell viability with the treatment of
cordycepin [28]. MA-10 cells were seeded in 96-well plate
(Techno Plastic Products AG, Trasadingen, Switzerland)
containing 2 × 104 cells with 100μL serum medium in each
well. After 70−80% conﬂuence, cells were treated without or
with 10μM, 100μM,1mM,2mMand5mMcordycepinfor
3, 6, 12, and 24h, respectively. MTT was added at diﬀerent
time points with the ﬁnal concentration of 0.5mg/mL, and
then incubated at 37◦Cf o r4h .T h em e d i u mw a sr e m o v e d
and DMSO (50μL) was added into each well to dissolve the
crystals by shaking the plate weakly for 20 min in dark. The
OD values in each treatment were then determined at λ =
590nm by an ELISA reader (Opsy MR, Dynex, USA).
2.6. Flow Cytometry Analysis. To further conﬁrm whether
cordycepin could induce cell apoptosis, the redistribution
of cell cycle by ﬂow cytometric analysis was used with
propidium iodine stain [29, 30]. MA-10 cells (6 × 105)w e r e
seededin6-cmdishwith2mLserummedium.After70−80%
conﬂuence, cells were treated with free medium containing
various concentrations of cordycepin for 3, 6, 12, and 24h,
respectively. Cordycepin-treated cells were harvested with
trypsin, washed with PBS, and mixed in 75% ethanol for
at least 2h at −20◦C. After ﬁxation, cells were washed
with cold PBS and then collected by centrifugation, mixed
with 100μg/mL RNase, and stained with PI (propidium
iodide) solution containing 40μg/mL in PBS. The stained
cells were analyzed using a ﬂuorescence activated cell sorter
(FACScan, Becton-Dickinson, Mountain View, CA, USA) at
λ = 488nm using Cell-Quest software (Becton-Dickinson,
Mountain View, CA, USA). The DNA content distribution
of normal growing cells is characterized by two peaks G1/G0
and G2/M phase. G1/G0 phase possesses normal functioning
andrestingstateofcellcyclewithmostdiploidDNAcontent,
while the DNA content in G2/M phase are more than
diploid. Cells in subG1 phase have least DNA content in cellEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: The eﬀect of cordycepin on morphological change and DNA fragmentation in MA-10 cells. MA-10 cells were treated without
(a), or with 10μM (b), 100μM (c), 1mM (d), 2mM (e) and 5mM (f) cordycepin for 24h. Morphological changes of cells were examined
under light microscopy (bar: 0.1mm; arrow heads: membrane blebbed cells). Also, gel electrophoresis of a 1kb DNA ladder marker (lane
M) or DNA isolated from MA-10 cells that were cultured for 24h in the presence of medium alone, 100μ or 1mM cordycepin (g). DNA was
visualized by ethidium bromide staining and photographed under UV illumination. Experiments were performed three times with similar
results (Con = control).
cycle distribution, called hypodiploid. The hypoploid DNA
contents represent the DNA fragmentation [30].
2.7. Immunoblotting Analysis. Cells (6 × 106) were seeded
in 6-cm dish. After treatment, cells were rinsed with cold
PBS. Cells were then harvested by 100μLl y s i sb u ﬀer (50mM
Tris-base, 150mM NaCl, 1% NP40, 0.1% SDS, 0.5% deoxy-
chloride acid and 1mM PMSF). Cell lysate was centrifuged
at 32000r.p.m. for 10 min at 4◦C. The pellet was collected
by 10μLl y s i sb u ﬀer and was centrifuged again at 12000g.
The supernatant, which contains total protein, was collected
a n ds t o r e da t−20◦C. Protein concentration of the cell lysates
were determined by the Lowry method [31]. Cell proteins
(40−60μg) were separated in 12% SDS−polyacrylamide gel,
that performed at 100V for 2.5h using standard running
buﬀer (24mM Tris−HCl, 0.19M glycine, 0.5% SDS, pH
8.3), and electrophoretically transferred to a polyvinylidene
diﬂuoride (PVDF) membrane at 400mA for 4h in transfer4 Evidence-Based Complementary and Alternative Medicine
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Figure 2:EﬀectsofcordycepinoncellviabilityofMA-10cells.Cells(5000cells/well)weretreatedwithdiﬀerentconcentrationsofcordycepin
(0.01−5mmol/L) for 3h (a), 6h (b), 12h (c) and 24h (d), respectively, and cell viability was quantiﬁed by MTT test. Results are expressed
as percentages of cell growth relative to initial number of viable cells in controls (as 100%). Data represent the mean ± SEM of four separate
experiments. ∗Groups diﬀering signiﬁcantly from control (P<. 05).
buﬀer (20mM Tris−HCl, 150mM glycine, 10% methanol,
0.01% SDS). The membranes were blocked with 5% nonfat
milk, washed by TBST (20mM Tris-base, 137Mm NaCl,
0.1% Tween 20, pH 7.6), and subsequently incubated with
primary caspase-3 or -7 antibodies at 1:4000 dilutions and
caspase-8 or -9 antibodies at 1:2000 dilutions overnight
at 4◦C. After washing, the membrane was incubated with
horseradish peroxidase-conjugated sheep anti-mouse anti-
body or donkey anti-rabbit antibody, and then visual-
ized by enhanced chemiluminescence (ECL) detection kit
(Amersharn-Pharmacia International PLC, UK). The optical
density of each protein band was quantitated by a Quantity
One (PDI, Huntington Station, NY, USA) computer-assisted
image analysis system [32]. The amount of β-actin in each
lane was also detected as a control to correct the expression
of caspases proteins.
2.8. Statistic Analysis. Each data point in the ﬁgures rep-
resents the mean ± SEM of three separate experiments.
Statistically signiﬁcant diﬀerences between treatments and
controls were determined by one-way ANOVA and then
Least Signiﬁcance Diﬀerence (LSD) comparison procedure.
Statistical signiﬁcance was set at P<. 05.
3. Results
3.1. Cordycepin-Induced Morphological Change and DNA
Fragmentation in MA-10 Cells. MA-10 cells were treated
without or with cordycepin (10μM, 100μM,1mM,2mM,
and 5mM) for 24h, and morphological changes were
observed under light microscopy. Cells without cordycepin
treatmentshowedpolygonalshapewithhealthyappearances,
blurred outline and ﬁrm attachment, which is normal cell
growth phenomenon (Figure 1(a)). Cells appeared rounded-
up phenomenon but still adherent to the ground matrix
with 10μM cordycepin (Figure 1(b). Cordycepin at 100μM
caused more cells rounded-up, and some cells expressed
plasma membrane blebbings (Figure 1(c)). More adherent
cells appeared membrane blebbings with more ﬂoating cells
under 1, 2, and 5mM cordycepin treatments, and the
number of attached cells reduced (Figures 1(d)−1(f)). These
phenomena suggest that cordycepin might induce apoptotic
cell death in MA-10 cells.
Previous results illustrated that cordycepin would cause
cell death in MA-10 cells. DNA fragmentation laddering
assay and ﬂow cytometry analysis were further used to
conﬁrm apoptotic eﬀect of cordycepin on MA-10 cells. TheEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: Cordycepin increased subG1 cell cycle phase in MA-10 cell line. The 3D histogram plot of ﬂow cytometry analysis in MA-10 cells
treated without or with cordycepin (10μM to 5mM) for 3h (a), 6h (b), 12h (c) and 24h (d), respectively. At the proper time points, cells
were ﬁxed, stained with propidium iodide, and analyzed of cell cycle progression by ﬂow cytometry as described in Section 2.S u b G 1= cells
with less than normal amount of DNA content; G1, cells in G1 cell cycle phase; G2/M, cells in G2/M cell cycle phase.
occurrence of DNA fragmentation is a characteristic event of
cell apoptosis with genomic DNA degrading into multiples
of 180−200bp units producing a ladder feature on agarose
gel electrophoresis. Figure 1(g) notably illustrates that DNA
fragmentations were observed in MA-10 cells with 24h
cordycepin treatment at 100μMa n d1m M .
3.2. Decreased MA-10 Cell Viability by Cordycepin. The
morphological changes suggested the involvement of cell
death induced by cordycepin in MA-10 cells. Thus, MTT
test was used to investigate the eﬀect of cordycepin on cell
viability in MA-10 cells. Cells were treated without or with
various concentrations (10μMt o5m M )o fc o r d y c e p i nf o r
diﬀerent time points (3, 6, 12, and 24h). MTT tests showed
that cordycepin induced death eﬀect on MA-10 cells in a
time- and dose-dependent manner (Figure 2).
Figure 2(a) illustrates that 3-h treatment of 1, 2, and
5mM cordycepin signiﬁcantly reduced cell viability to 76.8
± 4.3%, 67.9 ± 2.5% and 57.2 ± 5.7% (P<. 05), respectively,
in MA-10 cells. After 6h treatment with 1, 2, and 5mM
cordycepin, cell viability reduced to 78.8 ± 2.6%, 66.6 ±
2.6%, and 53.9 ± 3.4%, respectively (P < .05) (Figure 2(b)).
Treatment with 100μM, 1, 2, and 5mM cordycepin after
12h caused a reduction in cell viability to 73.0 ± 2.3%,
58.1 ± 3.8%, 25.7 ± 2.3% and 16.2 ± 0.6%, respectively
(P < 0.05) (Figure 2(c)). Moreover, treatment with 100μM,
1, 2 and 5mM cordycepin as 24h reduced cell viability to
73.1 ± 7.9%, 47.8 ± 1.6%, 15.0 ± 3.9% and 10.1 ± 1.2%,
respectively (P<. 05) (Figure 2(d)). The eﬀective cordycepin
concentration for 50% inhibition (EC50) on MA-10 cell
viability after 24h was 1mM. Thus, 100μMa n d1m Mw e r e
chosen for the subsequent experiments.
3.3. Cordycepin-Induced Cell Cycle Redistribution in MA-10
Cells. Moreover, in ﬂow cytometry analysis, DNA content
in each individual cell was determined. Figure 3 illus-
trates the distributions of PI stained MA-10 cells treated
with various concentrations of cordycepin (control, 10μM,6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: Quantiﬁcation in percentage of subG1 phase cell number. Statistical analysis from three independent experiments of Figure 3 with
diﬀerent concentrations of cordycepin (10μM to 5mM) regarding the change of cell cycle in percentages of subG1 phase for 3h (a), 6h (b),
12h (c), and 24h (d); in percentages of G1 phase for 3h (e), 6h (f), 12h (g) and 24h (h); and in percentages of G2/M phase for 3h (i),
6h (j), 12h (k), and 24h (l) was analyzed and illustrated. Data represent the mean ± SEM of three separate experiments. ∗Groups diﬀering
signiﬁcantly from control (P<. 05).
100μM, 1mM, 2mM, or 5mM) for 3h (Figure 3(a)),
6h(Figure 3(b)), 12h (Figure 3(c))a n d2 4h( Figure 3(d)),
respectively. The increases of subG1 phase in cell cycle
distribution could be observed at 3 and 6h treatments by
100μM cordycepin, and 12 and 24h by 100μMa n d1m M
cordycepin, respectively. Meanwhile, the decreases of cell
cycle distribution could only be observed in G1 phase by
cordycepin at 100μM and 1mM, or in G2/M phase by
cordycepin at 1mM for 24h treatment, respectively.
3.4. The Tendency and Analysis of Cell Cycle under Cordy-
cepin Inﬂuence in MA-10 Cells. Statistical analysis from
three independent experiments of Figure 3 with diﬀerent
concentration of cordycepin after 3, 6, 12, or 24h treatmentsEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: Participation of JNK, ROS and caspases in cordycepin-induced apoptosis. MA-10 cells were incubated with or without 100μM
cordycepin in the presence or absence of 1μM JNK inhibitor (SP600125 which abbreviated as SP) and 1mM ROS inhibitor (NAC) (a), or
100μM caspases inhibitor (b), respectively, for 24h, and the change of cell cycle in percentage of subG1 phase was analyzed and illustrated.
Data represent the mean ± SEM of three separate experiments. ∗Groups diﬀering signiﬁcantly from control (P<. 05). #Groups diﬀering
signiﬁcantly from 100μM cordycepin treatment.
regarding the change of subG1, G1, and G2/M phases of cell
cycle in percentages was analyzed and illustrated in Figure 4.
There was no signiﬁcant diﬀerence regarding the change of
subG1 phase after 3h cordycepin treatment (Figure 4(a)).
However, after 6h treatment, the subG1 phase signiﬁcantly
increased from 1.27% in control group to 7.64% in 100μM
cordycepin treatment group (Figure 4(b)) (P < .05). After
12h treatment, subG1 phase signiﬁcantly increased from
2.8% in control group to 23.1 and 11.4% in 100μMa n d
1mMcordycepintreatmentgroups,respectively(Figure 4(c)
(P<. 05). After 24h treatment, subG1 phase signiﬁcantly
increased from 4.4% in control group to 38.2 and 63.1% in
100μM and 1mM cordycepin treatment groups, respectively
(Figure 4(d) (P<. 05). In G1 phase, there were no
signiﬁcantdiﬀerencesbydiﬀerentdosagesofcordycepinafter
3, 6, and 12h treatments (Figures 4(e)−4(g)) (P<. 05).
100μMa n d1m Mc o r d y c e p i nt r e a t e dM A - 1 0c e l l sf o r2 4h
did signiﬁcantly decrease G1 phase from 56.3% in control
group to 23.1 and 18.1% in 100μM and 1mM cordycepin
treatment groups, respectively (Figure 4(h)) (P<. 05).
Moreover, only cordycepin at 1mM treatment for 24h could
signiﬁcantly decrease G2/M phase from 39.4% in control
group to 18.7% in cordycepin treatment group (Figure 4(l))
(P<. 05).
3.5. The Involvement of Cordycepin on ROS, JNK and/or
Caspase Pathways Related to Apoptosis in MA-10 Cells. To
investigate possible pathway that cordycepin might activate
to induce MA-10 cell apoptosis, cells were co-treated with
100μM cordycepin plus 1μM JNK inhibitor (SP600125),
1mM ROS inhibitor (NAC) or 100μM general caspase
inhibitor (zVAD-fmk) for 24h. The change of subG1 ratios
determinedbyﬂowcytometrywasthenanalyzed.Figure 5(a)
illustrates that subG1 ratio increased from 2.97% in control
group to 39.82% in 100μM cordycepin treatment after 24h
(P<. 05). JNK and ROS inhibitors could not suppress the
subG1 ratio (40.76 and 40.05%, resp.) back to control levels
(P>. 05). In caspase inhibitor experiment (Figure 5(b)),
the subG1 ratio increased from 1.78% in control group to
14.66% in cordycepin treatment after 24h (P<. 05). Inter-
estingly, general caspase inhibitor signiﬁcantly decreased
subG1 ratio to 9.26% (P<. 05). These results indicated
that caspase activation/pathway played roles in cordycepin-
induced apoptosis in MA-10 cells.
3.6.Cordycepin-InducedDiﬀerentialCaspasesProteinsExpres-
sion Related to Apoptosis in MA-10 Cells. Previous data
implied that caspase protein was involved in cordycepin-
activated apoptosis in MA-10 cells. We further deter-
mined whether cordycepin could induce caspase expression.
Figure 6(a)demonstratesimmunoblottingresultsofcaspase-
8, -9, -3 and -7 with cordycepin treatments (control,
100μMa n d1 m M )f o r0 ,1 ,3 ,6 ,1 2 ,a n d2 4 h ,r e s p e c -
tively.Figure 6(b)illustratesnosigniﬁcantdiﬀerencesamong
cordycepin treatments in each time point of caspase-8
expression (P>. 05). However, 1mM cordycepin (12h)
signiﬁcantly induced caspase-9 expression (P<. 05)
(Figure 6(c)),100μMcordycepin(6h)and1mMcordycepin
(24h) induced caspase-3 expression (P<. 05) (Figure 6(d))
and 100μM cordycepin (12h) signiﬁcantly induced caspase-
7 expression (Figure 6(e))( P<. 05). These results indicate
that cordycepin induced caspase-9, 3-, and -7 expressions,
but not caspase-8, to activate MA-10 cell apoptosis.
4. Discussion
In the present study, cordycepin would induce MA-10 cell
rounded-up with blebbed membrane, and reduced MA-
10 cell viability with apparent DNA fragmentation. It
is well known that internucleosomal DNA fragmentation
displays as a biochemical hallmark during apoptosis [33].
The induction of DNA fragmentation phenomenon by
cordycepin at 100μM for 24h correlated with the increase
of subG1 phase cell number of cytometry analysis, which8 Evidence-Based Complementary and Alternative Medicine
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Figure 6: The expression of eﬀector caspase-3 in cordycepin-induced apoptosis. Cells were treated without or with 100μM and 1mM
cordycepin for diﬀerent time (0, 1, 3, 6, 12, and 24h, resp.). Caspase-8 (16kDa), caspase-9 (37kDa), caspase-3 (19kDa) and caspase-7
(20kDa) speciﬁc bands were detected by Western blot. Immunoblot represents the observations from one single experiment repeated three
times (a). The integrated optical densities (IOD) of caspase-8, -9, -3, and -7 proteins after normalization with β-actin (43kDa) in each lane
using PDI image system were demonstrated in (b), (c), (d), and (e), respectively. Each data point in the ﬁgure represents the mean ± SEM
of three separate experiments. ∗Statistical diﬀerence compared to control (P<. 05).
conﬁrms that cordycepin could induce apoptosis in MA-
10 cells. Meanwhile, there were signiﬁcant decreases of G1
and G2/M phase cells. Moreover, caspases inhibitor, but not
JNK and ROS inhibitors, decreased subG1 ratio, implying
that caspase pathway played role in cordycepin-induced
apoptosis. Furthermore, cordycepin induced caspase-9, -3
and -7 expressions, but not caspase-8, to activate MA-10 cell
apoptosis.
Hyperphosphorylation of PAP from p34 cyclin B kinase
during mitosis will lead to the inactivation of PAP, which
contributes to the reduction of mRNA and protein synthesis
during the M phase of the cell cycle [34]. Also, PAP activity
levels are signiﬁcantly elevated at the G1/S phase of the cell
cycle, along with the increased rate of mRNA polyadenyla-
tion and accumulation in the cytoplasm [35]. In the present
s t u d y ,t r e a t m e n to fM A - 1 0c e l l sw i t hc o r d y c e p i nl e a dt o
the decreases of G1 and G2/M phases. It is possible that
cordycepin inhibited polyadenylation, which was necessary
at the G1/S phase of the cell cycle in order for all the required
mRNAs to be polyadenylated, transferred to the cytoplasmEvidence-Based Complementary and Alternative Medicine 9
and translated, in order for mitosis to take place. As a result,
mitosis will not ﬁnish, and cells will arrest at the onset of
apoptosis, since not all necessary proteins are translated.
Indeed, the decreases of G1 and G2/M phases may imply that
MA-10 cells were very sensitive to cordycepin since there was
no G2/M phase arrest.
Many evidences have demonstrated that excess ROS in
cell could induce cell apoptosis [22, 23, 36, 37]. An increase
inROSisalsoassociatedwiththeactivationofredoxsensitive
JNK/MAPK signaling pathway, which is often involved in
the transcriptional activation of genes and posttranslational
modiﬁcations of proteins necessary for apoptosis [23, 38].
Hence, in the present study, both JNK and ROS inhibitors
should be able to inhibit apoptotic eﬀect. Interestingly, JNK
inhibitor and ROS inhibitor could not decrease the subG1
ratio, which indicated that both JNK and ROS do not play
any role in cordycepin-induced apoptosis in MA-10 cells.
However, caspase inhibitor did suppress the subG1 ratio,
which highly suggested that caspase pathway was involved
in the cordycepin-induced apoptosis in MA-10 cells. Many
investigations have illustrated that caspases play essential
role in apoptosis [39]. Thus, our observations are not
unprecedented.
In the present study, 100μM and 1mM cordycepin
behaved diﬀerently to induce temporal expression of cas-
pases. In 100μM cordycepin treatment, the maximal expres-
sion of caspase-3 and -7 were at 6 and 12h, respectively.
Although there were increasing trends of caspases-8 and
-9 expressions at 12h, no signiﬁcances were observed. This
phenomenon illustrated that there was no caspase initiator
to activate eﬀector caspase-3 and -7. It has been shown that
other initiators, such as caspase-2 and/or caspase-10 can
activate eﬀector caspases [40, 41]. It is possible that 100μM
cordycepin could induce caspase-2 and/or caspase-10 to
activate caspase-3 and -7 expressions for cell apoptosis. In
1mM cordycepin treatment, caspase-9 expression (the ini-
tiator) signiﬁcantly increased ﬁrst at 12h, and then caspase-
3 (the eﬀector) increased at 24h, which illustrated a logical
temporal phenomenon to induce MA-10 cell apoptosis. The
possible mechanism of how diﬀerent dosages of cordycepin
regulating MA-10 cell apoptosis will be interesting to be
further investigated.
In general, the induction of caspase-9 is due to the
activation of mitochondrial apoptotic pathway, which can be
activated by cytochrome c, ROS and JNK pathway and/or
caspase-2 to induce cell apoptosis [42, 43]. In the present
study, we observed that caspase-9 was activated without any
involvement of ROS and JNK. It is possible that cordycepin
could induce cytochrome c, caspase-2 or other alternative
pathwaystoinducecaspase-9expressioninMA-10cells.This
indecision will be further examined.
It has been shown that cordycepin is an analog of
adenosine. The possibility of adenosine receptor involved in
apoptotic eﬀect on some types of cancer cell is also proposed
[44]. Thus, it is possible that cordycepin might associate
with adenosine receptor to activate apoptosis in MA-10 cells.
Future works regarding the investigation on the relations to
adenosine receptor in MA-10 cells will be valuable.
In conclusion, cordycepin could induce the decrease of
G1 and G2/M cell numbers and the increase of subG1 cell
number, followed by signiﬁcant apoptotic cell death in MA-
10 mouse Leydig cell line. The expressions of caspases also
demonstrate that cordycepin did induce apoptosis on MA-
10 mouse Leydig tumor cell line. Many Chinese herbs and
its pure compounds have been demonstrated with the anti-
cancer eﬀects [45, 46]. This promising observation about the
apoptoticeﬀectofcordycepinontesticularcancercellmaybe
considered as a good approach in search and development of
new anti-cancer drug.
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